A massive “if” NOX going broke in 2-3 years times has no impact on NYR. NOX has no impact on the drug, on the safety and on NYR. If NOX decide to leave in the next 2-3 years NYR will be at a billion dollar plus market cap anyway and will be doing an off market transfer.
NYR is a 18 million market cap with a drug now in human trials which has already has a proven mechanism of action of inhibiting calcium to reduce brain injury but also protecting the heart. You trolling this forum for a laugh does not in one bit affect me. It’s a 60-120 million dollar market cap on safety with a bigger potential than AGN and Zecs you will disappear.
You stating NYR has no pipeline says it all about your agenda when there are dozens of biotechs valued 100 million dollar plus market caps on preclinical studies and phase 1 on a single drug. It will come and again you will disappear and I promise you the company and share holders are coming
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)